MWNA
OGN icon

Marshall Wace North America’s Organon & Co OGN Stock Holding History

Marshall Wace North America’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$272K Sell
8,297
-1,534
-16% -$49.1K ﹤0.01% 1272
2021
Q2 		$297K Buy
+9,831
New +$324K ﹤0.01% 1283

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Marshall Wace North America's OGN Position: Q3 2021 in Review

Marshall Wace North America reduced its Organon & Co (OGN) stake by 16% in Q3 2021, selling an estimated $49.1K and leaving 8,297 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #1272.

Marshall Wace North America first reported a position in OGN in Q2 2021 and has held it in 2 quarters since. The position peaked at $297K in Q2 2021. 928 funds tracked by Wall St. Rank hold OGN as of Q3 2021.

  • Marshall Wace North America held 8,297 shares of Organon & Co worth $272K as of Q3 2021.
  • Marshall Wace North America sold 1,534 Organon & Co shares in Q3 2021, an estimated $49.1K.
  • Organon & Co made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1272 holding.
  • Marshall Wace North America first reported a position in Organon & Co in Q2 2021 and has held it in 2 quarters since.
  • Marshall Wace North America's Organon & Co position peaked at $297K in Q2 2021.
  • 928 funds tracked by Wall St. Rank held Organon & Co as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.